Repository logo
 
Publication

Portuguese National Serological Survey to Coronavirus Disease 19 - ISNCOVID-19

dc.contributor.authorKislaya, Irina
dc.contributor.authorGómez, Verónica
dc.contributor.authorGarcia, Ana Cristina
dc.contributor.authorMachado, Ausenda
dc.contributor.authorTorres, Ana Rita
dc.contributor.authorRoquette, Rita
dc.contributor.authorSousa-Uva, Mafalda
dc.contributor.authorMatias Dias, Carlos
dc.contributor.authorNunes, Baltazar
dc.contributor.authorCosta, Inês
dc.contributor.authorGonçalves, Paulo
dc.contributor.authorMatos, Rita
dc.contributor.authorMachado, Jorge
dc.contributor.authorManita, Carla
dc.contributor.authorMartins, Fátima
dc.contributor.authorSantos, João
dc.contributor.authorde Sousa, Rita
dc.contributor.authorSoeiro, Sofia
dc.contributor.authorRocha, Raquel
dc.contributor.authorRoque, Carla
dc.contributor.authorVerdasca, Nuno
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorISNCOVID-19 study team
dc.date.accessioned2021-03-10T16:11:44Z
dc.date.available2021-03-10T16:11:44Z
dc.date.issued2020-10
dc.description.abstractThe objective of this seroepidemiological survey was to estimate seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) specific antibodies (IgM and/or IgG) in Portugal in May-July 2020. The seroprevalence of SARS-Cov-2 infection (positive for IgM and/or IgG) was 2.9% (CI95: 2.0 - 4.2%). Our results support extend limited extent of infection by SARS-CoV-2 in Portugal due to early lockdown measures implementation.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/7410
dc.language.isoengpt_PT
dc.peerreviewednopt_PT
dc.publisherInstituto Nacional de Saúde Doutor Ricardo Jorge, IPpt_PT
dc.subjectSurveypt_PT
dc.subjectSARS-CoV-2pt_PT
dc.subjectSeroprevalencept_PT
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2pt_PT
dc.subjectCOVID-19pt_PT
dc.subjectInquérito Serológico Nacional COVID-19pt_PT
dc.subjectISN-COVID-19pt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.subjectEstados de Saúde e de Doença
dc.subjectPortugal
dc.titlePortuguese National Serological Survey to Coronavirus Disease 19 - ISNCOVID-19pt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceCopenhaga, Dinamarcapt_PT
oaire.citation.titleJoint ECDC and WHO/Europe meeting on COVID-19 Sero-epidemiological Studies, 29 October 2020pt_PT
rcaap.rightsclosedAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
SERO studies PT 29_10_2020_v2.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format